NasdaqGS:IARTMedical Equipment
Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes
Earlier in November 2025, Integra LifeSciences commended the Centers for Medicare & Medicaid Services (CMS) for including its entire portfolio of skin substitute products and dermal regenerative templates in the 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules.
This uniform reimbursement change by CMS is expected to broaden patient access to Integra’s wound reconstruction products and enhance the commercial potential across multiple care settings.
We’ll...